25 XP   0   0   10

Prim S.A.
Buy, Hold or Sell?

Let's analyse Prim together

PenkeI guess you are interested in Prim S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Prim S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Prim S.A.

I send you an email if I find something interesting about Prim S.A..

Quick analysis of Prim (30 sec.)










What can you expect buying and holding a share of Prim? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨1.58
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
‚ā¨7.40
Expected worth in 1 year
‚ā¨8.91
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
‚ā¨2.98
Return On Investment
28.1%

For what price can you sell your share?

Current Price per Share
‚ā¨10.60
Expected price per share
‚ā¨10.30 - ‚ā¨10.51
How sure are you?
50%

1. Valuation of Prim (5 min.)




Live pricePrice per Share (EOD)

‚ā¨10.60

Intrinsic Value Per Share

‚ā¨-34.88 - ‚ā¨-12.86

Total Value Per Share

‚ā¨-27.48 - ‚ā¨-5.47

2. Growth of Prim (5 min.)




Is Prim growing?

Current yearPrevious yearGrowGrow %
How rich?$135.4m$128.8m$6.5m4.9%

How much money is Prim making?

Current yearPrevious yearGrowGrow %
Making money$13.6m$9m$4.6m33.8%
Net Profit Margin5.9%4.3%--

How much money comes from the company's main activities?

3. Financial Health of Prim (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#93 / 170

Most Revenue
#50 / 170

Most Profit
#54 / 170

What can you expect buying and holding a share of Prim? (5 min.)

Welcome investor! Prim's management wants to use your money to grow the business. In return you get a share of Prim.

What can you expect buying and holding a share of Prim?

First you should know what it really means to hold a share of Prim. And how you can make/lose money.

Speculation

The Price per Share of Prim is ‚ā¨10.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Prim.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Prim, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨7.40. Based on the TTM, the Book Value Change Per Share is ‚ā¨0.38 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.37 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Prim.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps0.807.6%0.807.6%0.535.0%0.716.7%0.747.0%
Usd Book Value Change Per Share0.413.8%0.413.8%-0.04-0.4%0.242.3%0.262.5%
Usd Dividend Per Share0.393.7%0.393.7%0.565.3%0.484.5%0.474.4%
Usd Total Gains Per Share0.807.6%0.807.6%0.524.9%0.726.8%0.736.9%
Usd Price Per Share11.25-11.25-11.63-12.26-10.98-
Price to Earnings Ratio14.03-14.03-21.96-18.47-15.49-
Price-to-Total Gains Ratio14.02-14.02-22.44-17.73-15.65-
Price to Book Ratio1.41-1.41-1.54-1.66-1.60-
Price-to-Total Gains Ratio14.02-14.02-22.44-17.73-15.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.41302
Number of shares87
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.390.48
Usd Book Value Change Per Share0.410.24
Usd Total Gains Per Share0.800.72
Gains per Quarter (87 shares)69.8462.43
Gains per Year (87 shares)279.38249.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
113714226916684240
2275284548332167490
3412426827499251740
45505681106665334990
568771013858314181240
682585216649975011490
7962994194311635851740
810991136222213306681990
912371278250114967522240
1013741420278016628352490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%18.02.00.090.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%

Fundamentals of Prim

About Prim S.A.

Prim, S.A. provides health technology, mobility, and health care products in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company also provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors. It offers its products under the OrthoPrim, AirMed, Airtex, Airtex Plus, aqtivo skin, aqtivo sport, ComforGel, ComforGel Lady, ComforSil, Essencial, Mottio, MyPrim, Neoprair, Neoprair One Size, PrimSpine, and Olium brands. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.

Fundamental data was last updated by Penke on 2024-06-09 20:39:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Prim S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Prim earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 5.9%¬†means that¬†€0.06 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Prim S.A.:

  • The MRQ is 5.9%. The company is making a profit. +1
  • The TTM is 5.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.9%0.0%
TTM5.9%YOY4.3%+1.6%
TTM5.9%5Y6.5%-0.7%
5Y6.5%10Y8.8%-2.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%5.7%+0.2%
TTM5.9%6.0%-0.1%
YOY4.3%5.1%-0.8%
5Y6.5%7.2%-0.7%
10Y8.8%6.9%+1.9%
1.1.2. Return on Assets

Shows how efficient Prim is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • 6.3% Return on Assets means that¬†Prim generated¬†€0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Prim S.A.:

  • The MRQ is 6.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.3%TTM6.3%0.0%
TTM6.3%YOY4.5%+1.8%
TTM6.3%5Y6.5%-0.1%
5Y6.5%10Y8.1%-1.6%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3%0.8%+5.5%
TTM6.3%0.9%+5.4%
YOY4.5%1.4%+3.1%
5Y6.5%1.5%+5.0%
10Y8.1%1.6%+6.5%
1.1.3. Return on Equity

Shows how efficient Prim is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • 10.1% Return on Equity means Prim generated €0.10¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Prim S.A.:

  • The MRQ is 10.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY7.0%+3.1%
TTM10.1%5Y9.5%+0.5%
5Y9.5%10Y10.9%-1.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%1.4%+8.7%
TTM10.1%1.8%+8.3%
YOY7.0%2.7%+4.3%
5Y9.5%3.1%+6.4%
10Y10.9%2.8%+8.1%

1.2. Operating Efficiency of Prim S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Prim is operating .

  • Measures how much profit Prim makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • An Operating Margin of 6.6%¬†means the company generated €0.07 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Prim S.A.:

  • The MRQ is 6.6%. The company is operating less efficient.
  • The TTM is 6.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM6.6%0.0%
TTM6.6%YOY6.6%+0.0%
TTM6.6%5Y9.1%-2.5%
5Y9.1%10Y11.6%-2.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%7.7%-1.1%
TTM6.6%4.8%+1.8%
YOY6.6%9.1%-2.5%
5Y9.1%9.5%-0.4%
10Y11.6%9.6%+2.0%
1.2.2. Operating Ratio

Measures how efficient Prim is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are €0.93 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Prim S.A.:

  • The MRQ is 0.934. The company is less efficient in keeping operating costs low.
  • The TTM is 0.934. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.934TTM0.9340.000
TTM0.934YOY0.941-0.008
TTM0.9345Y0.915+0.019
5Y0.91510Y0.897+0.018
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9341.100-0.166
TTM0.9341.124-0.190
YOY0.9411.153-0.212
5Y0.9151.084-0.169
10Y0.8971.044-0.147

1.3. Liquidity of Prim S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Prim is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.33¬†means the company has €2.33 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Prim S.A.:

  • The MRQ is 2.326. The company is able to pay all its short-term debts. +1
  • The TTM is 2.326. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.326TTM2.3260.000
TTM2.326YOY2.697-0.370
TTM2.3265Y2.903-0.576
5Y2.90310Y3.312-0.410
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3262.293+0.033
TTM2.3262.339-0.013
YOY2.6972.551+0.146
5Y2.9032.659+0.244
10Y3.3122.645+0.667
1.3.2. Quick Ratio

Measures if Prim is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.32¬†means the company can pay off €1.32 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Prim S.A.:

  • The MRQ is 1.321. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.321. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.321TTM1.3210.000
TTM1.321YOY1.343-0.021
TTM1.3215Y1.649-0.328
5Y1.64910Y2.230-0.580
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3211.010+0.311
TTM1.3211.042+0.279
YOY1.3431.223+0.120
5Y1.6491.348+0.301
10Y2.2301.537+0.693

1.4. Solvency of Prim S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Prim assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Prim to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.37¬†means that Prim assets are¬†financed with 37.1% credit (debt) and the remaining percentage (100% - 37.1%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Prim S.A.:

  • The MRQ is 0.371. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.371. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.3710.000
TTM0.371YOY0.353+0.018
TTM0.3715Y0.325+0.046
5Y0.32510Y0.269+0.056
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.357+0.014
TTM0.3710.357+0.014
YOY0.3530.344+0.009
5Y0.3250.361-0.036
10Y0.2690.364-0.095
1.4.2. Debt to Equity Ratio

Measures if Prim is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 59.0% means that company has €0.59 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Prim S.A.:

  • The MRQ is 0.590. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.590. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.590TTM0.5900.000
TTM0.590YOY0.545+0.045
TTM0.5905Y0.486+0.105
5Y0.48610Y0.379+0.107
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5900.529+0.061
TTM0.5900.558+0.032
YOY0.5450.516+0.029
5Y0.4860.622-0.136
10Y0.3790.642-0.263

2. Market Valuation of Prim S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Prim generates.

  • Above 15 is considered overpriced but¬†always compare¬†Prim to the¬†Medical Instruments & Supplies industry mean.
  • A PE ratio of 14.03 means the investor is paying €14.03¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Prim S.A.:

  • The EOD is 14.230. Based on the earnings, the company is underpriced. +1
  • The MRQ is 14.028. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.028. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.230MRQ14.028+0.201
MRQ14.028TTM14.0280.000
TTM14.028YOY21.957-7.928
TTM14.0285Y18.468-4.439
5Y18.46810Y15.495+2.973
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD14.23016.707-2.477
MRQ14.02816.779-2.751
TTM14.02816.479-2.451
YOY21.95719.971+1.986
5Y18.46820.830-2.362
10Y15.49527.678-12.183
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Prim S.A.:

  • The EOD is -4.357. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.296. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.296. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.357MRQ-4.296-0.062
MRQ-4.296TTM-4.2960.000
TTM-4.296YOY-15.465+11.169
TTM-4.2965Y-19.827+15.531
5Y-19.82710Y26.066-45.893
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-4.357-0.624-3.733
MRQ-4.296-0.457-3.839
TTM-4.2966.154-10.450
YOY-15.4652.642-18.107
5Y-19.8277.971-27.798
10Y26.0661.279+24.787
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Prim is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.41 means the investor is paying €1.41¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Prim S.A.:

  • The EOD is 1.433. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.413. Based on the equity, the company is underpriced. +1
  • The TTM is 1.413. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.433MRQ1.413+0.020
MRQ1.413TTM1.4130.000
TTM1.413YOY1.539-0.126
TTM1.4135Y1.661-0.248
5Y1.66110Y1.601+0.060
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD1.4332.569-1.136
MRQ1.4132.683-1.270
TTM1.4132.700-1.287
YOY1.5392.954-1.415
5Y1.6614.016-2.355
10Y1.6014.442-2.841
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Prim S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3790.3790%-0.037+110%0.223+70%0.241+57%
Book Value Per Share--7.3967.3960%7.017+5%6.866+8%6.345+17%
Current Ratio--2.3262.3260%2.697-14%2.903-20%3.312-30%
Debt To Asset Ratio--0.3710.3710%0.353+5%0.325+14%0.269+38%
Debt To Equity Ratio--0.5900.5900%0.545+8%0.486+22%0.379+56%
Dividend Per Share--0.3670.3670%0.518-29%0.444-17%0.437-16%
Eps--0.7450.7450%0.492+51%0.659+13%0.689+8%
Free Cash Flow Per Share---2.433-2.4330%-0.698-71%-0.914-62%-0.299-88%
Free Cash Flow To Equity Per Share---0.631-0.6310%-1.413+124%-0.904+43%-0.534-15%
Gross Profit Margin--0.6990.6990%0.666+5%0.785-11%0.854-18%
Intrinsic Value_10Y_max---12.864--------
Intrinsic Value_10Y_min---34.875--------
Intrinsic Value_1Y_max---0.513--------
Intrinsic Value_1Y_min---1.860--------
Intrinsic Value_3Y_max---2.133--------
Intrinsic Value_3Y_min---7.039--------
Intrinsic Value_5Y_max---4.466--------
Intrinsic Value_5Y_min---13.765--------
Market Cap180328260.000+1%177776445.000177776445.0000%184243626.000-4%195791820.700-9%175396640.160+1%
Net Profit Margin--0.0590.0590%0.043+38%0.065-10%0.088-33%
Operating Margin--0.0660.0660%0.066+1%0.091-27%0.116-43%
Operating Ratio--0.9340.9340%0.941-1%0.915+2%0.897+4%
Pb Ratio1.433+1%1.4131.4130%1.539-8%1.661-15%1.601-12%
Pe Ratio14.230+1%14.02814.0280%21.957-36%18.468-24%15.495-9%
Price Per Share10.600+1%10.45010.4500%10.800-3%11.390-8%10.201+2%
Price To Free Cash Flow Ratio-4.357-1%-4.296-4.2960%-15.465+260%-19.827+362%26.066-116%
Price To Total Gains Ratio14.216+1%14.01514.0150%22.440-38%17.732-21%15.648-10%
Quick Ratio--1.3211.3210%1.343-2%1.649-20%2.230-41%
Return On Assets--0.0630.0630%0.045+40%0.065-2%0.081-21%
Return On Equity--0.1010.1010%0.070+44%0.095+6%0.109-8%
Total Gains Per Share--0.7460.7460%0.481+55%0.666+12%0.678+10%
Usd Book Value--135472601.235135472601.2350%128891853.903+5%127006306.500+7%117409193.490+15%
Usd Book Value Change Per Share--0.4080.4080%-0.040+110%0.240+70%0.260+57%
Usd Book Value Per Share--7.9637.9630%7.555+5%7.392+8%6.832+17%
Usd Dividend Per Share--0.3950.3950%0.558-29%0.478-17%0.470-16%
Usd Eps--0.8020.8020%0.530+51%0.710+13%0.742+8%
Usd Free Cash Flow---44559229.500-44559229.5000%-12827551.411-71%-16828028.284-62%-5483751.930-88%
Usd Free Cash Flow Per Share---2.619-2.6190%-0.752-71%-0.984-62%-0.321-88%
Usd Free Cash Flow To Equity Per Share---0.680-0.6800%-1.521+124%-0.974+43%-0.575-15%
Usd Market Cap194159437.542+1%191411898.332191411898.3320%198375112.114-4%210809053.348-9%188849562.460+1%
Usd Price Per Share11.413+1%11.25211.2520%11.628-3%12.264-8%10.983+2%
Usd Profit--13644556.11913644556.1190%9034878.256+51%12192950.040+12%12748099.561+7%
Usd Revenue--233116317.000233116317.0000%212373770.099+10%189626314.341+23%155026074.135+50%
Usd Total Gains Per Share--0.8030.8030%0.518+55%0.718+12%0.730+10%
 EOD+5 -3MRQTTM+0 -0YOY+22 -145Y+17 -1910Y+17 -19

3.2. Fundamental Score

Let's check the fundamental score of Prim S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.230
Price to Book Ratio (EOD)Between0-11.433
Net Profit Margin (MRQ)Greater than00.059
Operating Margin (MRQ)Greater than00.066
Quick Ratio (MRQ)Greater than11.321
Current Ratio (MRQ)Greater than12.326
Debt to Asset Ratio (MRQ)Less than10.371
Debt to Equity Ratio (MRQ)Less than10.590
Return on Equity (MRQ)Greater than0.150.101
Return on Assets (MRQ)Greater than0.050.063
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Prim S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose10.600
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Stockholders Equity  -10,2154,271-5,945-13,390-19,33510,976-8,35913,5785,220
Net Interest Income  1,014-2777372739-163575-1,116-540
Total Operating Expenses  62,392-2,44959,9435,98065,92317,07883,001-84,211-1,210



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets200,100
Total Liabilities74,278
Total Stockholder Equity125,796
 As reported
Total Liabilities 74,278
Total Stockholder Equity+ 125,796
Total Assets = 200,100

Assets

Total Assets200,100
Total Current Assets144,467
Long-term Assets55,634
Total Current Assets
Cash And Cash Equivalents 6,439
Short-term Investments 6,809
Net Receivables 62,000
Inventory 68,846
Other Current Assets 372
Total Current Assets  (as reported)144,467
Total Current Assets  (calculated)144,467
+/-0
Long-term Assets
Property Plant Equipment 24,368
Goodwill 9,537
Intangible Assets 14,194
Long-term Assets Other 0
Long-term Assets  (as reported)55,634
Long-term Assets  (calculated)48,099
+/- 7,535

Liabilities & Shareholders' Equity

Total Current Liabilities62,102
Long-term Liabilities12,176
Total Stockholder Equity125,796
Total Current Liabilities
Short-term Debt 16,964
Short Long Term Debt 14,818
Accounts payable 28,875
Other Current Liabilities 15,121
Total Current Liabilities  (as reported)62,102
Total Current Liabilities  (calculated)75,778
+/- 13,676
Long-term Liabilities
Long term Debt 3,899
Capital Lease Obligations 6,764
Long-term Liabilities Other 481
Long-term Liabilities  (as reported)12,176
Long-term Liabilities  (calculated)11,144
+/- 1,032
Total Stockholder Equity
Common Stock4,259
Retained Earnings 12,673
Accumulated Other Comprehensive Income 228
Other Stockholders Equity 5,220
Total Stockholder Equity (as reported)125,796
Total Stockholder Equity (calculated)22,380
+/- 103,416
Other
Capital Stock4,259
Cash and Short Term Investments 13,248
Common Stock Shares Outstanding 17,010
Current Deferred Revenue1,142
Liabilities and Stockholders Equity 200,100
Net Debt 18,987
Net Invested Capital 144,539
Net Working Capital 82,364
Property Plant and Equipment Gross 66,990
Short Long Term Debt Total 25,426



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
66,057
78,416
82,442
85,754
94,039
99,975
110,751
117,884
104,893
108,549
116,543
116,214
128,292
137,766
138,306
149,659
163,645
179,850
184,994
200,100
200,100184,994179,850163,645149,659138,306137,766128,292116,214116,543108,549104,893117,884110,75199,97594,03985,75482,44278,41666,057
   > Total Current Assets 
39,158
49,797
49,899
55,271
63,054
67,044
77,792
84,180
82,016
74,484
77,065
82,863
88,405
100,062
99,879
109,514
123,630
135,918
131,361
144,467
144,467131,361135,918123,630109,51499,879100,06288,40582,86377,06574,48482,01684,18077,79267,04463,05455,27149,89949,79739,158
       Cash And Cash Equivalents 
1,285
1,659
2,032
3,395
913
2,470
1,448
901
2,008
2,101
9,274
3,801
6,217
15,674
8,805
5,519
31,771
32,335
10,877
6,439
6,43910,87732,33531,7715,5198,80515,6746,2173,8019,2742,1012,0089011,4482,4709133,3952,0321,6591,285
       Short-term Investments 
12
860
94
275
178
591
145
280
17,693
874
4,417
15,136
15,167
8,355
8,065
4,800
3,388
4,203
4,064
6,809
6,8094,0644,2033,3884,8008,0658,35515,16715,1364,41787417,6932801455911782759486012
       Net Receivables 
0
0
0
0
0
0
0
0
0
53,033
42,559
37,623
33,343
35,679
38,701
46,956
38,632
37,052
46,405
62,000
62,00046,40537,05238,63246,95638,70135,67933,34337,62342,55953,033000000000
       Inventory 
13,178
15,808
17,170
20,034
22,181
20,372
22,121
20,209
16,840
17,791
19,830
25,537
31,252
37,682
41,469
48,363
46,355
56,316
64,117
68,846
68,84664,11756,31646,35548,36341,46937,68231,25225,53719,83017,79116,84020,20922,12120,37222,18120,03417,17015,80813,178
   > Long-term Assets 
26,899
28,619
32,544
30,483
30,985
32,932
32,959
33,704
22,878
34,065
39,478
33,351
39,887
37,704
38,428
40,145
40,015
43,932
53,632
55,634
55,63453,63243,93240,01540,14538,42837,70439,88733,35139,47834,06522,87833,70432,95932,93230,98530,48332,54428,61926,899
       Property Plant Equipment 
11,412
11,714
10,942
10,892
11,166
11,401
11,573
11,092
10,297
9,513
9,509
9,037
9,017
9,142
10,735
15,070
16,616
21,057
23,664
24,368
24,36823,66421,05716,61615,07010,7359,1429,0179,0379,5099,51310,29711,09211,57311,40111,16610,89210,94211,71411,412
       Goodwill 
0
0
2,229
0
0
0
2,229
2,229
1,574
1,574
1,574
1,574
3,606
4,175
4,175
4,175
4,175
4,931
9,173
9,537
9,5379,1734,9314,1754,1754,1754,1753,6061,5741,5741,5741,5742,2292,2290002,22900
       Long Term Investments 
0
0
0
0
0
0
0
0
0
16,370
24,319
18,634
20,313
17,861
15,900
13,678
0
0
0
0
000013,67815,90017,86120,31318,63424,31916,370000000000
       Intangible Assets 
0
0
149
0
0
0
299
230
206
180
284
214
3,223
3,167
4,369
4,019
3,483
4,343
9,785
14,194
14,1949,7854,3433,4834,0194,3693,1673,22321428418020623029900014900
       Long-term Assets Other 
11,371
11,042
13,360
10,597
8,664
12,419
13,706
15,273
23,719
37,344
15,771
37,285
37,068
23,004
11,124
7,808
6,309
7,089
6,828
0
06,8287,0896,3097,80811,12423,00437,06837,28515,77137,34423,71915,27313,70612,4198,66410,59713,36011,04211,371
> Total Liabilities 
33,165
42,519
40,118
36,858
39,650
37,757
43,273
45,698
26,693
23,792
23,879
23,967
27,447
31,699
29,469
38,609
51,905
58,378
65,284
74,278
74,27865,28458,37851,90538,60929,46931,69927,44723,96723,87923,79226,69345,69843,27337,75739,65036,85840,11842,51933,165
   > Total Current Liabilities 
16,712
19,083
21,735
22,738
24,207
27,223
26,885
30,724
22,745
18,772
20,095
21,317
23,385
28,781
27,505
33,497
37,925
45,910
48,713
62,102
62,10248,71345,91037,92533,49727,50528,78123,38521,31720,09518,77222,74530,72426,88527,22324,20722,73821,73519,08316,712
       Short-term Debt 
3,811
3,655
4,402
5,172
4,751
9,618
10,435
15,014
6,558
3,097
2,243
2,326
1,641
2,140
765
4,708
7,301
7,993
10,279
16,964
16,96410,2797,9937,3014,7087652,1401,6412,3262,2433,0976,55815,01410,4359,6184,7515,1724,4023,6553,811
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
5,589
698
702
1,641
2,140
765
3,556
6,359
6,056
8,186
14,818
14,8188,1866,0566,3593,5567652,1401,6417026985,589000000000
       Accounts payable 
11,484
13,967
15,912
15,673
17,295
15,984
14,609
14,978
6,939
6,466
7,062
8,413
10,092
12,264
12,703
13,965
13,047
23,982
18,229
28,875
28,87518,22923,98213,04713,96512,70312,26410,0928,4137,0626,4666,93914,97814,60915,98417,29515,67315,91213,96711,484
       Other Current Liabilities 
1,417
1,461
1,420
1,893
2,161
1,621
1,841
732
9,248
9,209
10,791
10,578
11,651
14,377
14,036
12,989
16,267
11,455
-10,279
15,121
15,121-10,27911,45516,26712,98914,03614,37711,65110,57810,7919,2099,2487321,8411,6212,1611,8931,4201,4611,417
   > Long-term Liabilities 
16,453
23,436
18,383
14,120
15,443
10,534
16,387
14,974
3,948
5,020
3,783
2,650
4,062
2,918
1,965
5,112
13,980
12,468
16,571
12,176
12,17616,57112,46813,9805,1121,9652,9184,0622,6503,7835,0203,94814,97416,38710,53415,44314,12018,38323,43616,453
       Other Liabilities 
0
0
0
0
0
0
0
0
0
2,534
2,997
2,529
4,062
2,918
1,965
1,665
877
1,445
4,821
0
04,8211,4458771,6651,9652,9184,0622,5292,9972,534000000000
> Total Stockholder Equity
32,891
35,897
42,324
48,896
54,389
62,218
67,478
72,186
78,200
84,757
92,665
92,246
100,845
106,067
108,837
111,051
111,740
121,472
119,710
125,796
125,796119,710121,472111,740111,051108,837106,067100,84592,24692,66584,75778,20072,18667,47862,21854,38948,89642,32435,89732,891
   Common Stock
2,693
2,962
3,258
3,584
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,337
4,278
4,259
4,2594,2784,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3373,5843,2582,9622,693
   Retained Earnings 
4,744
5,711
7,555
10,060
9,904
10,035
8,532
8,909
9,135
9,634
9,962
10,703
13,097
13,898
14,119
11,218
6,917
17,423
8,391
12,673
12,6738,39117,4236,91711,21814,11913,89813,09710,7039,9629,6349,1358,9098,53210,0359,90410,0607,5555,7114,744
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
25,454
27,224
31,511
35,251
40,148
47,846
54,610
58,940
64,729
70,786
78,366
77,207
83,411
87,832
90,381
-10,215
-5,945
-19,335
-8,359
5,220
5,220-8,359-19,335-5,945-10,21590,38187,83283,41177,20778,36670,78664,72958,94054,61047,84640,14835,25131,51127,22425,454



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.